Enough with data collection, FDA needs diversity policies to boost representation in clinical trials: report

Home / Media Center / Trinity in the News / Enough with data collection, FDA needs diversity policies to boost representation in clinical trials: report

Fierce Biotech  |  March 9, 2022

Trinity’s recent white paper, titled Diversity in Clinical Trials Participation: A Life Sciences Perspective, was featured in a recent article by Fierce Biotech.